Recursion Cost Of Revenue from 2010 to 2025

RXRX Stock  USD 6.58  0.11  1.70%   
Recursion Pharmaceuticals Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 33.9 M in 2025. During the period from 2010 to 2025, Recursion Pharmaceuticals Cost Of Revenue regression line of annual values had r-squared of  0.06 and arithmetic mean of  43,782,746. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
45.2 M
Current Value
33.9 M
Quarterly Volatility
10.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Recursion Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Recursion Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 14.9 M, Interest Income of 16.5 M or Depreciation And Amortization of 38.3 M, as well as many indicators such as Price To Sales Ratio of 29.93, Dividend Yield of 0.0 or PTB Ratio of 1.88. Recursion financial statements analysis is a perfect complement when working with Recursion Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Recursion Pharmaceuticals Correlation against competitors.
For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.

Latest Recursion Pharmaceuticals' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Recursion Pharmaceuticals over the last few years. Cost of Revenue is found on Recursion Pharmaceuticals income statement and represents the costs associated with goods and services Recursion Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Recursion Pharmaceuticals' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Recursion Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Pretty Stable
   Cost Of Revenue   
       Timeline  

Recursion Cost Of Revenue Regression Statistics

Arithmetic Mean43,782,746
Geometric Mean41,382,794
Coefficient Of Variation24.65
Mean Deviation5,718,288
Median45,809,000
Standard Deviation10,790,484
Sample Variance116.4T
Range54.2M
R-Value(0.24)
Mean Square Error117.6T
R-Squared0.06
Significance0.37
Slope(541,951)
Total Sum of Squares1746.5T

Recursion Cost Of Revenue History

202533.9 M
202445.2 M
202342.6 M
202248.3 M
20219.1 M
202063.3 M

About Recursion Pharmaceuticals Financial Statements

Recursion Pharmaceuticals investors use historical fundamental indicators, such as Recursion Pharmaceuticals' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Recursion Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue45.2 M33.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Recursion Stock Analysis

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.